GlassScriptPhysician profile
Ashley Best
NPI 1871168997
$2,988.62
in general payments reported to CMS, 2019-2025
25 companies · $208 in 2025
The $208 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $181 · 2022: $1,529 · 2023: $823 · 2024: $248 · 2025: $208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,276 · Education: $3.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,275.60 |
| Education | $3.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $959.86 | 2021-2023 | Fasenra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $344.92 | 2021-2022 | |
| Insmed, INC. | $292.89 | 2021-2023 | Arikayce |
| Glaxosmithkline, LLC. | $287.31 | 2021-2023 | Arexvy, Trelegy Ellipta, Shingrix |
| Genzyme Corporation | $158.99 | 2023 | |
| Amgen INC. | $155.89 | 2022 | |
| Smith+Nephew, INC. | $101.35 | 2024-2025 | Stravix, Grafix Pl |
| Medical Device Business Services, INC. | $97.18 | 2024 | Stratafix |
| Grifols USA, LLC | $96.68 | 2022-2023 | Prolastin-C Liquid |
| Solventum Corporation | $73.56 | 2024 | Prevena Restor Arthroform, Prevena, Prevena Restor Axioform |
| Baxter Healthcare | $53.84 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Endo USA, INC. | $42.43 | 2025 | Xiaflex |
| Pacira Pharmaceuticals Incorporated | $41.45 | 2025 | Zilretta, Iovera |
| Mylan Specialty L.P. | $36.34 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $36.08 | 2023 | Opsumit, Uptravi |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $27.68 | 2025 | |
| Convatec INC. | $25.49 | 2025 | |
| Octapharma USA, INC. | $23.19 | 2025 | Octagam Immune Globulin (Human) |
| Moximed, INC | $23.12 | 2025 | Misha Knee System, Small, Left |
| Inogen, INC. | $20.90 | 2022 | |
| Genentech USA, INC. | $20.81 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.20 | 2022 | |
| Jazz Pharmaceuticals INC. | $20.13 | 2022 | |
| Harmony Biosciences LLC | $16.50 | 2022 | |
| United Therapeutics Corporation | $11.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Best listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.